FIELD: medicine, narcology. SUBSTANCE: method involves determination of blood plasma prolactin content during remission every month. Tactivin is prescribed if this index is increased by 30%, not less, as compared with normal value. Tactivin is administrated by subcutaneous route at the dose 1.0 every day for 5-7 days. EFFECT: prolonged remission period. 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ALCOHOLICS | 1996 |
|
RU2136295C1 |
| METHOD FOR PREDICTING THE DURATION OF THERAPEUTIC REMISSION IN PATIENTS WITH ALCOHOLISM | 2021 |
|
RU2756613C1 |
| METHOD FOR PREDICTION OF DURATION OF THERAPEUTIC REMISSION IN ALCOHOL DEPENDENCE | 2019 |
|
RU2726409C1 |
| METHOD FOR PREDICTING UNSTABLE THERAPEUTIC REMISSION IN ALCOHOL DEPENDENCE | 2021 |
|
RU2776568C1 |
| METHOD FOR DIAGNOSING THE CASES OF PATHOLOGICAL ATTRACTION TO ALCOHOL CONSUMPTION | 1996 |
|
RU2139674C1 |
| METHOD FOR CORRECTION OF IMMUNE DISTURBANCE IN OPIUM NARCOMANIA | 2003 |
|
RU2254128C2 |
| METHOD OF PREVENTING RECURRENCES OF OPIUM ADDICTION | 2010 |
|
RU2428123C1 |
| METHOD FOR TREATING ALCOHOLISM | 1991 |
|
RU2057549C1 |
| METHOD FOR TREATING THE CASES OF ALCOHOL ADDICTION | 2003 |
|
RU2254149C1 |
| METHOD FOR PREVENTING OPIUM ADDICTION RECURRENCE | 2006 |
|
RU2312688C1 |
